1-(4-甲氧基苯基)-3-甲基-1H-吡唑-5-胺 、 4-苯基-2,4-二氧丁酸乙酯 以to give the title compound as a solid (2.5 g, 87%) sufficiently pure for the next step的产率得到1-(4-methoxyphenyl)-3-methyl-6-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid ethyl ester
参考文献:
名称:
New positive allosteric modulators of nicotinic acetylcholine receptor
[EN] PYRAZOLOPYRIDINES USEFUL IN THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM<br/>[FR] PYRAZOLOPYRIDINES UTILES DANS LE TRAITEMENT DE TROUBLES DU SYSTÈME NERVEUX CENTRAL
申请人:LUNDBECK & CO AS H
公开号:WO2013004617A1
公开(公告)日:2013-01-10
The present invention relates to compounds useful in therapy, to compositions comprising said compounds, and to methods of treating diseases comprising administration of said com- pounds. The compounds referred to are positive allosteric modulators (PAMs) of the nicotinic acetylcholine α7 receptor.